<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02099240</url>
  </required_header>
  <id_info>
    <org_study_id>14.0185</org_study_id>
    <nct_id>NCT02099240</nct_id>
  </id_info>
  <brief_title>Patients Response to Early Switch To Oral:Osteomyelitis Study</brief_title>
  <acronym>PRESTO:Osteo</acronym>
  <official_title>Prospective Randomized Study to Compare Clinical Outcomes in Patients With Osteomyelitis Treated With Intravenous Antibiotics Versus Intravenous Antibiotics With an Early Switch to Oral Antibiotics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Julio Ramirez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Based on the current literature, investigators hypothesize that patients with osteomyelitis&#xD;
      who are treated with the standard approach of intravenous antibiotics for the full duration&#xD;
      of therapy will have the same clinical outcomes as patients treated with the experimental&#xD;
      approach of intravenous antibiotics with early switch to oral antibiotics.&#xD;
&#xD;
      The primary objective of this study is to compare patients with osteomyelitis treated with&#xD;
      the standard approach of intravenous antibiotics for the full duration of therapy versus&#xD;
      patients treated with intravenous antibiotics with an early switch to oral antibiotics in&#xD;
      relation to clinical outcomes at 12 months after discontinuation of antibiotic therapy.&#xD;
      Secondary objectives of the study include the evaluation of adverse events related to the use&#xD;
      of antibiotics as well as the cost of care evaluated from the hospital perspective.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1.1. Background Information Osteomyelitis is a common disease associated with significant&#xD;
      morbidity and high cost (1). The treatment of osteomyelitis can be challenging requiring&#xD;
      prolonged administration of antibiotics and extensive surgical procedures. Even when the&#xD;
      infection is treated, the relapse rate is as high as 20% (2). When a bone is infected, the&#xD;
      local multiplication of bacteria produces a local inflammatory response with presence of&#xD;
      neutrophils and macrophages with areas of microthrombi and avascular necrosis. If a&#xD;
      significant area of avascular necrosis develops, a segment of the bone without any blood&#xD;
      supply can become separated and form a sequestrum. Since infection of sequestrum occurs in&#xD;
      most patients with osteomyelitis, it is considered that in addition to antibiotic treatment,&#xD;
      the patient requires surgical intervention for removal of necrotic bone.&#xD;
&#xD;
      1.2. Scientific Rationale There is agreement regarding the minimal duration of antibiotic&#xD;
      therapy for patients with osteomyelitis. Since an infected bone may take 3 to 4 weeks to&#xD;
      re--- vascularize, the duration of therapy should be a minimum of 4 to 6 weeks of&#xD;
      antibiotics. Because different organisms can cause osteomyelitis, the initial antibiotic&#xD;
      therapy during hospitalization should include broad---spectrum antibiotics to cover the most&#xD;
      likely organisms. As part of the initial management, a bone biopsy is regularly performed to&#xD;
      identify the particular etiologic agent. Once the organism and its antimicrobial&#xD;
      susceptibilities are known, the spectrum of antibiotic therapy is narrowed, and the&#xD;
      antimicrobial therapy continues with an antibiotic that is targeted according to the&#xD;
      susceptibility of the identified pathogen. Targeted antibiotic therapy in patients with&#xD;
      osteomyelitis is usually performed after 3 to 5 days of broad spectrum antibiotics, since&#xD;
      this is the time required by the microbiology department to generate antimicrobial&#xD;
      susceptibilities after the bone biopsy is performed. In regard to the route of antibiotic&#xD;
      administration, the standard approach is to use an intravenous antibiotic.&#xD;
&#xD;
      1.3. Potential Risks A potential risk for the use of an early switch to oral antibiotics in&#xD;
      patients with osteomyelitis is that the blood level achieved with oral antibiotics may not be&#xD;
      high enough to attain clinical resolution of the infection.&#xD;
&#xD;
      1.4. Potential Benefits There are several potential benefits of using oral antibiotics&#xD;
      instead of intravenous antibiotics. First, avoiding a peripherally inserted central line&#xD;
      eliminates the risk of line infection and line---associated deep vein thrombosis. An early&#xD;
      switch to oral antibiotics may also facilitate early hospital discharge. A shorter hospital&#xD;
      stay will decrease the risk of hospital---associated complications such as&#xD;
      hospital---acquired infections. Further, the patients' quality of life may be better without&#xD;
      a central line. Finally, the total cost of therapy will be significantly reduced with oral&#xD;
      therapy.&#xD;
&#xD;
      2. Methods 2.1. Trial design &amp; setting This will be a prospective, randomized, unblinded&#xD;
      clinical trial to define if the clinical outcomes of patients with osteomyelitis treated with&#xD;
      the experimental approach of intravenous antibiotics with an early switch to oral therapy is&#xD;
      non---inferior to the current standard approach of intravenous antibiotics for the full&#xD;
      duration of therapy.&#xD;
&#xD;
      2.8. Sample Size &amp; Statistical Analysis The null hypothesis for this study will be as&#xD;
      follows: H0: πs --- πe ≤ ---Δ Where πs is the proportion of clinical failures in the&#xD;
      intravenous therapy only group, πe is the proportion of clinical failures in the intravenous&#xD;
      therapy plus early switch to oral therapy group, and Δ is the non---inferiority margin. The&#xD;
      alternative hypothesis will be: HA: πs --- πe &gt; ---Δ We expect that there will be a 20%&#xD;
      clinical failure rate for the primary outcome in both the intravenous antibiotic therapy&#xD;
      group and the intravenous antibiotic therapy plus early switch to oral antibiotic therapy&#xD;
      group. The study will be powered at 80% with Δ of 0.1. A total of 396 patients will be needed&#xD;
      to obtain a 95% confidence interval for the difference in failure rates between the two&#xD;
      groups that has a lower limit above ---Δ. If the lower limit of this 95% confidence interval&#xD;
      for the 10 difference in clinical failure rates between the two arms is above -Δ,&#xD;
      non---inferiority will be met. Considering that approximately 15% of patients will be lost&#xD;
      during study follow---up, a total of 456 patients will be enroll in the trial to obtain the&#xD;
      396 patients necessary for final analyses.&#xD;
&#xD;
      3. Data Quality Management Plan 3.1. Overview of the Clinical and Translational Research&#xD;
      Support Center&#xD;
&#xD;
      The University of Louisville Clinical and Translational Research Support Center (CTRSC) will&#xD;
      be responsible for data collection, data quality, and data analysis for this project. The&#xD;
      CTRSC (http://www.ctrsc.net) is a multi---disciplinary team comprised of professionals in&#xD;
      medicine, public health, statistics, and computer science. The team has considerable&#xD;
      experience managing and supporting single---site and multi---center clinical research&#xD;
      studies. Specifically, members of the CTRSC will be responsible for:&#xD;
&#xD;
        -  Study design&#xD;
&#xD;
        -  Development of data collection forms&#xD;
&#xD;
        -  Development of study manual 11&#xD;
&#xD;
        -  Development of electronic Internet base data entry system&#xD;
&#xD;
        -  Providing instruction on use of forms and data entry system&#xD;
&#xD;
        -  Development of study database&#xD;
&#xD;
        -  Tracking subject enrollment&#xD;
&#xD;
        -  Overseeing data transmission&#xD;
&#xD;
        -  Providing data management&#xD;
&#xD;
        -  Handling data validation&#xD;
&#xD;
        -  Protecting confidentiality of data&#xD;
&#xD;
        -  Performing feasibility evaluation The data quality team leader for this project will be&#xD;
           Dr. Robert Kelley with assistance from Dr. Timothy Wiemken and Dr. Paula Peyrani.&#xD;
&#xD;
      The CTRSC has access to the University of Louisville's high---performance computing cluster,&#xD;
      which consists of 312 IBM iDatplex nodes each with two Intel Xeon quad--- core processors for&#xD;
      2496 total cores. The cluster is equipped with a variety of statistical and bioinformatics&#xD;
      software including SAS, R, Matlab, ClustalW, and Blast, and C, Fortran, Perl, and Python&#xD;
      libraries. In addition, the CTRSC has several iMac and IBM---compatible workstations with&#xD;
      several data management and analysis packages installed including R, Matlab, SQL Server 2012,&#xD;
      SAS, SPSS, Eclipse, Visual Studio .NET 2010, MySQL Server 5.1, Tableau 8.0, and REDCap.&#xD;
&#xD;
      3.2. Purpose of Data Quality Management Plan&#xD;
&#xD;
      The purpose of this data quality management plan is outline the procedures and processes&#xD;
      necessary to:&#xD;
&#xD;
        1. Ensure the data collection and data management for the study are conducted in a manner&#xD;
           consistent with University of Louisville standards as well as state and federal&#xD;
           regulations.&#xD;
&#xD;
        2. Ensure that data collected are accurate and complete when verified against source&#xD;
           documents.&#xD;
&#xD;
        3. Provide approaches for early interception and correction of errors in data collection.&#xD;
&#xD;
        4. Identify areas where specific education and training efforts regarding data collection&#xD;
           need to be focused.&#xD;
&#xD;
        5. Outline the tools that will be used to monitor and assess data quality.&#xD;
&#xD;
        6. Outline the Data Quality Management Team meeting schedule for this project. 3.3. Data&#xD;
           Capture Primary data collection will be performed by a qualified study coordinator(s)&#xD;
           who will abstract subject data from the electronic medical record onto a paper case&#xD;
           report form. Once the paper case report form is complete, the study coordinator or other&#xD;
           designee will enter the data into a secure, web---based clinical data management system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Not enough patient enrollment and lack of staffing&#xD;
  </why_stopped>
  <start_date type="Actual">March 6, 2014</start_date>
  <completion_date type="Actual">November 7, 2018</completion_date>
  <primary_completion_date type="Actual">November 7, 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Failures</measure>
    <time_frame>1 month</time_frame>
    <description>Clinical failure will be defined as clinical or laboratory evidence of infection collected from the patient's medical record documents.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of adverse events related to the use of antibiotics</measure>
    <time_frame>1 month</time_frame>
    <description>Antibiotic---related adverse events will be defined according to the Food and Drug Administration adverse events listed in the package insert of the antibiotic prescribed for each subject.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of care from the hospital perspective</measure>
    <time_frame>12 months</time_frame>
    <description>Costs will be calculated from the hospital perspective and will include the costs of the antibiotic therapy, home healthcare (nursing--- and infusion---related), and length of hospital stay.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Osteomyelitis</condition>
  <arm_group>
    <arm_group_label>Intravenous antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous antibiotics for the full duration of therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oral antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intravenous antibiotic therapy plus early switch to oral antibiotic therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral antibiotics</intervention_name>
    <description>intravenous antibiotics with early switch to oral antibiotics, antibiotic type will be dependent on bacteria type</description>
    <arm_group_label>oral antibiotics</arm_group_label>
    <other_name>Amoxicillin</other_name>
    <other_name>Amoxil®</other_name>
    <other_name>Ampicillin</other_name>
    <other_name>Omnipen®</other_name>
    <other_name>Bacampicillin</other_name>
    <other_name>Spectrobid®</other_name>
    <other_name>Carbenicillin Indanyl</other_name>
    <other_name>Pyopen®, Geogen®, Geocillin®</other_name>
    <other_name>Mezlocillin</other_name>
    <other_name>Mezlin®</other_name>
    <other_name>Piperacillin*</other_name>
    <other_name>Pipracil®</other_name>
    <other_name>Ticarcillin</other_name>
    <other_name>Ticar®</other_name>
    <other_name>Amoxicillin-Clavulanic Acid</other_name>
    <other_name>Augmentin®</other_name>
    <other_name>Ampicillin-Sulbactam*</other_name>
    <other_name>Unasyn®</other_name>
    <other_name>Benzylpenicillin</other_name>
    <other_name>Benpen®</other_name>
    <other_name>Cloxacillin</other_name>
    <other_name>Tegopen®, Coxapen®</other_name>
    <other_name>Dicloxacillin</other_name>
    <other_name>Dycill®, Dynapen®, Pathocil®</other_name>
    <other_name>Methicillin</other_name>
    <other_name>Staphcillin®</other_name>
    <other_name>Oxacillin</other_name>
    <other_name>Prostaphilin®, Bactocil®</other_name>
    <other_name>Penicillin G (Benzathine, Potassium, Procaine)</other_name>
    <other_name>Bicillin® C-R/L-A, Pfizerpen®, Wycellin®</other_name>
    <other_name>Penicillin V</other_name>
    <other_name>Pen-Veek®, Beepen-VK®</other_name>
    <other_name>Piperacillin+Tazobactam*</other_name>
    <other_name>Zozyn®</other_name>
    <other_name>Ticarcillin+Clavulanic Acid</other_name>
    <other_name>Timentin®</other_name>
    <other_name>Nafcillin</other_name>
    <other_name>Unipen®, Nafcil®</other_name>
    <other_name>Cefaclor</other_name>
    <other_name>Ceclor®, Ceclor CD®</other_name>
    <other_name>Cefamandol</other_name>
    <other_name>Mandol®</other_name>
    <other_name>Cefonicid</other_name>
    <other_name>Monocid®</other_name>
    <other_name>Cefotetan</other_name>
    <other_name>Cefotan®</other_name>
    <other_name>Cefoxitin</other_name>
    <other_name>Mefoxin®</other_name>
    <other_name>Cefprozil</other_name>
    <other_name>Cefzil®</other_name>
    <other_name>Ceftmetazole</other_name>
    <other_name>Zefazone®</other_name>
    <other_name>Cefuroxime</other_name>
    <other_name>Kefurox®, Zinacef®</other_name>
    <other_name>Cefuroxime axetil</other_name>
    <other_name>Ceftin®</other_name>
    <other_name>Loracarbef</other_name>
    <other_name>Lorabid®Cefdinir</other_name>
    <other_name>Omnicef®</other_name>
    <other_name>Ceftibuten</other_name>
    <other_name>Cedax®</other_name>
    <other_name>Cefoperazone</other_name>
    <other_name>Cefobid®</other_name>
    <other_name>Cefixime*</other_name>
    <other_name>Suprax®</other_name>
    <other_name>Cefotaxime*</other_name>
    <other_name>Claforan®</other_name>
    <other_name>Cefpodoxime proxetil</other_name>
    <other_name>Vantin®</other_name>
    <other_name>Ceftazidime*</other_name>
    <other_name>Ceptaz®, Fortaz®, Tanicef®</other_name>
    <other_name>Ceftizoxime*</other_name>
    <other_name>Cefizox®</other_name>
    <other_name>Ceftriaxone*</other_name>
    <other_name>Rocephin®</other_name>
    <other_name>Cefepime</other_name>
    <other_name>Maxipime®</other_name>
    <other_name>Azithromycin*</other_name>
    <other_name>Zithromax®</other_name>
    <other_name>Clarithromycin*</other_name>
    <other_name>Biaxin®</other_name>
    <other_name>Clindamycin</other_name>
    <other_name>Cleocin®</other_name>
    <other_name>Dirithromycin</other_name>
    <other_name>Dynabac®</other_name>
    <other_name>Erythromycin</other_name>
    <other_name>E-mycin®, Ery-tab®, Benzamycin®</other_name>
    <other_name>Lincomycin</other_name>
    <other_name>Lincocin®</other_name>
    <other_name>T roleandomycin</other_name>
    <other_name>T ao®</other_name>
    <other_name>Cinoxacin</other_name>
    <other_name>Cinoxacin®</other_name>
    <other_name>Ciprofloxacin*</other_name>
    <other_name>Cipro®</other_name>
    <other_name>Enoxacin</other_name>
    <other_name>Penetrex®</other_name>
    <other_name>Gatifloxacin</other_name>
    <other_name>T equin®</other_name>
    <other_name>Grepafloxacin</other_name>
    <other_name>Levofloxacin</other_name>
    <other_name>Levaquin®, Quixin®</other_name>
    <other_name>Lomefloxacin</other_name>
    <other_name>Maxaquin®</other_name>
    <other_name>Moxifloxacin</other_name>
    <other_name>A velox®</other_name>
    <other_name>Nalidixic acid</other_name>
    <other_name>NegGam®</other_name>
    <other_name>Norfloxacin*</other_name>
    <other_name>Noroxin®</other_name>
    <other_name>Ofloxacin</other_name>
    <other_name>Floxin®</other_name>
    <other_name>Sparfloxacin</other_name>
    <other_name>Zagam®</other_name>
    <other_name>T rovafloxacin</other_name>
    <other_name>T rovan®</other_name>
    <other_name>Imipenem-Cilastatin*</other_name>
    <other_name>Primaxin®</other_name>
    <other_name>Meropenem</other_name>
    <other_name>Merrem®</other_name>
    <other_name>Aztreonam*</other_name>
    <other_name>Azactam®</other_name>
    <other_name>Amikacin*</other_name>
    <other_name>Amikin®</other_name>
    <other_name>Gentamicin</other_name>
    <other_name>Garamycin®</other_name>
    <other_name>Kanamycin</other_name>
    <other_name>Kantrex®</other_name>
    <other_name>Neomycin</other_name>
    <other_name>Mycifradin®, Neo-Fradin®</other_name>
    <other_name>Netilmicin</other_name>
    <other_name>Netromycin®</other_name>
    <other_name>Streptomycin</other_name>
    <other_name>Streptomycin®</other_name>
    <other_name>T obramycin*</other_name>
    <other_name>Tobrex®, Nebcin®</other_name>
    <other_name>Paromomycin</other_name>
    <other_name>Humatin®</other_name>
    <other_name>T eicoplanin</other_name>
    <other_name>T argocid®</other_name>
    <other_name>Vancomycin*</other_name>
    <other_name>Vancocyn®, Lyphocin®</other_name>
    <other_name>Demeclocycline</other_name>
    <other_name>Declomycin®</other_name>
    <other_name>Doxycycline</other_name>
    <other_name>Doxy®, Vibra®, Vibramycin®</other_name>
    <other_name>Methacycline</other_name>
    <other_name>Rondomycin®</other_name>
    <other_name>Minocycline</other_name>
    <other_name>Minocin®</other_name>
    <other_name>Oxytetracycline</other_name>
    <other_name>Terramycin®</other_name>
    <other_name>T etracycline</other_name>
    <other_name>Sumycin®</other_name>
    <other_name>Chlortetracycline</other_name>
    <other_name>Mafenide</other_name>
    <other_name>Sulfamylon®</other_name>
    <other_name>Silver Sulfadiazine</other_name>
    <other_name>SSD®, Silvadene®</other_name>
    <other_name>Sulfacetamide</other_name>
    <other_name>Sultrim®</other_name>
    <other_name>Sulfadiazine</other_name>
    <other_name>Sulfamethoxazole</other_name>
    <other_name>Gantanol®</other_name>
    <other_name>Sulfasalazine</other_name>
    <other_name>Sulfasalazine®,Azulfidine®</other_name>
    <other_name>Sulfisoxazole</other_name>
    <other_name>T rimethoprim-Sulfamethoxazole</other_name>
    <other_name>Bactrim®, Septra®, Cofatrim®, Primsol®</other_name>
    <other_name>Sulfamethizole</other_name>
    <other_name>Thiosulfil Forte®</other_name>
    <other_name>Rifabutin</other_name>
    <other_name>Mycobutin®</other_name>
    <other_name>Rifampin</other_name>
    <other_name>Rifadin®</other_name>
    <other_name>Rifapentine</other_name>
    <other_name>Priftin®</other_name>
    <other_name>Linezolid*</other_name>
    <other_name>Zyvox®</other_name>
    <other_name>Quinopristin+Dalfopristin*</other_name>
    <other_name>Synercid®</other_name>
    <other_name>Bacitracin</other_name>
    <other_name>Baci-IM</other_name>
    <other_name>Chloramphenicol*</other_name>
    <other_name>Chloromycetin®</other_name>
    <other_name>Colistemetate</other_name>
    <other_name>Coly-Mycin® M &amp; S</other_name>
    <other_name>Fosfomycin</other_name>
    <other_name>Monurol®</other_name>
    <other_name>Isoniazid</other_name>
    <other_name>Rifamate®</other_name>
    <other_name>Methenamine</other_name>
    <other_name>Hiprex®, Mandelamine®</other_name>
    <other_name>Metronidazol</other_name>
    <other_name>Flagyl®</other_name>
    <other_name>Mupirocin</other_name>
    <other_name>Bactroban®</other_name>
    <other_name>Nitrofurantoin</other_name>
    <other_name>Macrobid®, Macrodantin®, Furantoin®</other_name>
    <other_name>Nitrofurazone</other_name>
    <other_name>Furacin®</other_name>
    <other_name>Novobiocin</other_name>
    <other_name>Albamycin®</other_name>
    <other_name>Polymyxin B</other_name>
    <other_name>Aerospin®</other_name>
    <other_name>Spectinomycin</other_name>
    <other_name>T robicin®</other_name>
    <other_name>T rimethoprim</other_name>
    <other_name>Proloprim®, Trimpex®</other_name>
    <other_name>Colistin</other_name>
    <other_name>Cycloserine</other_name>
    <other_name>Capreomycin</other_name>
    <other_name>Ethionamide</other_name>
    <other_name>Pyrazinamide</other_name>
    <other_name>Para-aminosalicyclic acid</other_name>
    <other_name>Erythromycin ethylsuccinate + sulfisoxazole</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intravenous antibiotics</intervention_name>
    <description>intravenous antibiotics for the full duration of therapy, antibiotic type will be dependent on bacteria type</description>
    <arm_group_label>Intravenous antibiotics</arm_group_label>
    <other_name>Amoxicillin</other_name>
    <other_name>Amoxil®</other_name>
    <other_name>Ampicillin</other_name>
    <other_name>Omnipen®</other_name>
    <other_name>Bacampicillin</other_name>
    <other_name>Spectrobid®</other_name>
    <other_name>Carbenicillin Indanyl</other_name>
    <other_name>Pyopen®, Geogen®, Geocillin®</other_name>
    <other_name>Mezlocillin</other_name>
    <other_name>Mezlin®</other_name>
    <other_name>Piperacillin*</other_name>
    <other_name>Pipracil®</other_name>
    <other_name>Ticarcillin</other_name>
    <other_name>Ticar®</other_name>
    <other_name>Amoxicillin-Clavulanic Acid</other_name>
    <other_name>Augmentin®</other_name>
    <other_name>Ampicillin-Sulbactam*</other_name>
    <other_name>Unasyn®</other_name>
    <other_name>Benzylpenicillin</other_name>
    <other_name>Benpen®</other_name>
    <other_name>Cloxacillin</other_name>
    <other_name>Tegopen®, Coxapen®</other_name>
    <other_name>Dicloxacillin</other_name>
    <other_name>Dycill®, Dynapen®, Pathocil®</other_name>
    <other_name>Methicillin</other_name>
    <other_name>Staphcillin®</other_name>
    <other_name>Oxacillin</other_name>
    <other_name>Prostaphilin®, Bactocil®</other_name>
    <other_name>Penicillin G (Benzathine, Potassium, Procaine)</other_name>
    <other_name>Bicillin® C-R/L-A, Pfizerpen®, Wycellin®</other_name>
    <other_name>Penicillin V</other_name>
    <other_name>Pen-Veek®, Beepen-VK®</other_name>
    <other_name>Piperacillin+Tazobactam*</other_name>
    <other_name>Zozyn®</other_name>
    <other_name>Ticarcillin+Clavulanic Acid</other_name>
    <other_name>Timentin®</other_name>
    <other_name>Nafcillin</other_name>
    <other_name>Unipen®, Nafcil®</other_name>
    <other_name>Cefaclor</other_name>
    <other_name>Ceclor®, Ceclor CD®</other_name>
    <other_name>Cefamandol</other_name>
    <other_name>Mandol®</other_name>
    <other_name>Cefonicid</other_name>
    <other_name>Monocid®</other_name>
    <other_name>Cefotetan</other_name>
    <other_name>Cefotan®</other_name>
    <other_name>Cefoxitin</other_name>
    <other_name>Mefoxin®</other_name>
    <other_name>Cefprozil</other_name>
    <other_name>Cefzil®</other_name>
    <other_name>Ceftmetazole</other_name>
    <other_name>Zefazone®</other_name>
    <other_name>Cefuroxime</other_name>
    <other_name>Kefurox®, Zinacef®</other_name>
    <other_name>Cefuroxime axetil</other_name>
    <other_name>Ceftin®</other_name>
    <other_name>Loracarbef</other_name>
    <other_name>Lorabid®Cefdinir</other_name>
    <other_name>Omnicef®</other_name>
    <other_name>Ceftibuten</other_name>
    <other_name>Cedax®</other_name>
    <other_name>Cefoperazone</other_name>
    <other_name>Cefobid®</other_name>
    <other_name>Cefixime*</other_name>
    <other_name>Suprax®</other_name>
    <other_name>Cefotaxime*</other_name>
    <other_name>Claforan®</other_name>
    <other_name>Cefpodoxime proxetil</other_name>
    <other_name>Vantin®</other_name>
    <other_name>Ceftazidime*</other_name>
    <other_name>Ceptaz®, Fortaz®, Tanicef®</other_name>
    <other_name>Ceftizoxime*</other_name>
    <other_name>Cefizox®</other_name>
    <other_name>Ceftriaxone*</other_name>
    <other_name>Rocephin®</other_name>
    <other_name>Cefepime</other_name>
    <other_name>Maxipime®</other_name>
    <other_name>Azithromycin*</other_name>
    <other_name>Zithromax®</other_name>
    <other_name>Clarithromycin*</other_name>
    <other_name>Biaxin®</other_name>
    <other_name>Clindamycin</other_name>
    <other_name>Cleocin®</other_name>
    <other_name>Dirithromycin</other_name>
    <other_name>Dynabac®</other_name>
    <other_name>Erythromycin</other_name>
    <other_name>E-mycin®, Ery-tab®, Benzamycin®</other_name>
    <other_name>Lincomycin</other_name>
    <other_name>Lincocin®</other_name>
    <other_name>T roleandomycin</other_name>
    <other_name>T ao®</other_name>
    <other_name>Cinoxacin</other_name>
    <other_name>Cinoxacin®</other_name>
    <other_name>Ciprofloxacin*</other_name>
    <other_name>Cipro®</other_name>
    <other_name>Enoxacin</other_name>
    <other_name>Penetrex®</other_name>
    <other_name>Gatifloxacin</other_name>
    <other_name>T equin®</other_name>
    <other_name>Grepafloxacin</other_name>
    <other_name>Levofloxacin</other_name>
    <other_name>Levaquin®, Quixin®</other_name>
    <other_name>Lomefloxacin</other_name>
    <other_name>Maxaquin®</other_name>
    <other_name>Moxifloxacin</other_name>
    <other_name>A velox®</other_name>
    <other_name>Nalidixic acid</other_name>
    <other_name>NegGam®</other_name>
    <other_name>Norfloxacin*</other_name>
    <other_name>Noroxin®</other_name>
    <other_name>Ofloxacin</other_name>
    <other_name>Floxin®</other_name>
    <other_name>Sparfloxacin</other_name>
    <other_name>Zagam®</other_name>
    <other_name>T rovafloxacin</other_name>
    <other_name>T rovan®</other_name>
    <other_name>Imipenem-Cilastatin*</other_name>
    <other_name>Primaxin®</other_name>
    <other_name>Meropenem</other_name>
    <other_name>Merrem®</other_name>
    <other_name>Aztreonam*</other_name>
    <other_name>Azactam®</other_name>
    <other_name>Amikacin*</other_name>
    <other_name>Amikin®</other_name>
    <other_name>Gentamicin</other_name>
    <other_name>Garamycin®</other_name>
    <other_name>Kanamycin</other_name>
    <other_name>Kantrex®</other_name>
    <other_name>Neomycin</other_name>
    <other_name>Mycifradin®, Neo-Fradin®</other_name>
    <other_name>Netilmicin</other_name>
    <other_name>Netromycin®</other_name>
    <other_name>Streptomycin</other_name>
    <other_name>Streptomycin®</other_name>
    <other_name>T obramycin*</other_name>
    <other_name>Tobrex®, Nebcin®</other_name>
    <other_name>Paromomycin</other_name>
    <other_name>Humatin®</other_name>
    <other_name>T eicoplanin</other_name>
    <other_name>T argocid®</other_name>
    <other_name>Vancomycin*</other_name>
    <other_name>Vancocyn®, Lyphocin®</other_name>
    <other_name>Demeclocycline</other_name>
    <other_name>Declomycin®</other_name>
    <other_name>Doxycycline</other_name>
    <other_name>Doxy®, Vibra®, Vibramycin®</other_name>
    <other_name>Methacycline</other_name>
    <other_name>Rondomycin®</other_name>
    <other_name>Minocycline</other_name>
    <other_name>Minocin®</other_name>
    <other_name>Oxytetracycline</other_name>
    <other_name>Terramycin®</other_name>
    <other_name>T etracycline</other_name>
    <other_name>Sumycin®</other_name>
    <other_name>Chlortetracycline</other_name>
    <other_name>Mafenide</other_name>
    <other_name>Sulfamylon®</other_name>
    <other_name>Silver Sulfadiazine</other_name>
    <other_name>SSD®, Silvadene®</other_name>
    <other_name>Sulfacetamide</other_name>
    <other_name>Sultrim®</other_name>
    <other_name>Sulfadiazine</other_name>
    <other_name>Sulfamethoxazole</other_name>
    <other_name>Gantanol®</other_name>
    <other_name>Sulfasalazine</other_name>
    <other_name>Sulfasalazine®,Azulfidine®</other_name>
    <other_name>Sulfisoxazole</other_name>
    <other_name>T rimethoprim-Sulfamethoxazole</other_name>
    <other_name>Bactrim®, Septra®, Cofatrim®, Primsol®</other_name>
    <other_name>Sulfamethizole</other_name>
    <other_name>Thiosulfil Forte®</other_name>
    <other_name>Rifabutin</other_name>
    <other_name>Mycobutin®</other_name>
    <other_name>Rifampin</other_name>
    <other_name>Rifadin®</other_name>
    <other_name>Rifapentine</other_name>
    <other_name>Priftin®</other_name>
    <other_name>Linezolid*</other_name>
    <other_name>Zyvox®</other_name>
    <other_name>Quinopristin+Dalfopristin*</other_name>
    <other_name>Synercid®</other_name>
    <other_name>Bacitracin</other_name>
    <other_name>Baci-IM</other_name>
    <other_name>Chloramphenicol*</other_name>
    <other_name>Chloromycetin®</other_name>
    <other_name>Colistemetate</other_name>
    <other_name>Coly-Mycin® M &amp; S</other_name>
    <other_name>Fosfomycin</other_name>
    <other_name>Monurol®</other_name>
    <other_name>Isoniazid</other_name>
    <other_name>Rifamate®</other_name>
    <other_name>Methenamine</other_name>
    <other_name>Hiprex®, Mandelamine®</other_name>
    <other_name>Metronidazol</other_name>
    <other_name>Flagyl®</other_name>
    <other_name>Mupirocin</other_name>
    <other_name>Bactroban®</other_name>
    <other_name>Nitrofurantoin</other_name>
    <other_name>Macrobid®, Macrodantin®, Furantoin®</other_name>
    <other_name>Nitrofurazone</other_name>
    <other_name>Furacin®</other_name>
    <other_name>Novobiocin</other_name>
    <other_name>Albamycin®</other_name>
    <other_name>Polymyxin B</other_name>
    <other_name>Aerospin®</other_name>
    <other_name>Spectinomycin</other_name>
    <other_name>T robicin®</other_name>
    <other_name>T rimethoprim</other_name>
    <other_name>Proloprim®, Trimpex®</other_name>
    <other_name>Colistin</other_name>
    <other_name>Cycloserine</other_name>
    <other_name>Capreomycin</other_name>
    <other_name>Ethionamide</other_name>
    <other_name>Pyrazinamide</other_name>
    <other_name>Para-aminosalicyclic acid</other_name>
    <other_name>Erythromycin ethylsuccinate + sulfisoxazole</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Only adult patients will be invited to participate in this trial (age ≥ 18 years). A&#xD;
             patient will be considered a candidate to participate in this trial if the following&#xD;
             two inclusion criteria are present:&#xD;
&#xD;
               1. Isolation of an organism from bone culture that is susceptible to intravenous and&#xD;
                  oral antibiotics.&#xD;
&#xD;
               2. Plus at least one of the following:&#xD;
&#xD;
                    -  Evidence of local inflammatory response, manifested as local pain, edema,&#xD;
                       erythema, warmth, or drainage.&#xD;
&#xD;
                    -  Evidence of systemic inflammatory response, manifested as fever, elevated&#xD;
                       C---reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), or&#xD;
                       white blood cell count.&#xD;
&#xD;
          -  *Osteomyelitis---compatible findings on plain radiograph, computed tomography, bone&#xD;
             scan, magnetic resonance imaging, or positron emission tomography.&#xD;
&#xD;
               -  Pathology report indicative of osteomyelitis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A patient will not be considered as a candidate to participate in this study if the&#xD;
             study team expects the subject to be non---compliant with the study follow---up clinic&#xD;
             visit.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Seligson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julio Ramirez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004 Jul 24-30;364(9431):369-79. Review.</citation>
    <PMID>15276398</PMID>
  </results_reference>
  <results_reference>
    <citation>Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med. 1996 Nov;101(5):550-61. Review.</citation>
    <PMID>8948280</PMID>
  </results_reference>
  <results_reference>
    <citation>Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970 Jan 22;282(4):198-206. Review.</citation>
    <PMID>4902833</PMID>
  </results_reference>
  <results_reference>
    <citation>Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis. 2005 May;9(3):127-38. Review.</citation>
    <PMID>15840453</PMID>
  </results_reference>
  <results_reference>
    <citation>Conterno LO, da Silva Filho CR. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004439. doi: 10.1002/14651858.CD004439.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;9:CD004439.</citation>
    <PMID>19588358</PMID>
  </results_reference>
  <results_reference>
    <citation>Peyrani P, Allen M, Seligson D, Roberts C, Chen A, Haque N, Zervos M, Wiemken T, Harting J, Christensen D, Ramirez R. Clinical outcomes of osteomyelitis patients infected with methicillin-resistant Staphylococcus aureus USA-300 strains. Am J Orthop (Belle Mead NJ). 2012 Mar;41(3):117-22.</citation>
    <PMID>22530208</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 18, 2014</study_first_submitted>
  <study_first_submitted_qc>March 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2014</study_first_posted>
  <last_update_submitted>April 2, 2021</last_update_submitted>
  <last_update_submitted_qc>April 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Julio Ramirez</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Osteomyelitis</keyword>
  <keyword>IV Antibiotics</keyword>
  <keyword>Oral Antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteomyelitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Azithromycin</mesh_term>
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Clarithromycin</mesh_term>
    <mesh_term>Doxycycline</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Levofloxacin</mesh_term>
    <mesh_term>Ofloxacin</mesh_term>
    <mesh_term>Minocycline</mesh_term>
    <mesh_term>Rifampin</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Isoniazid</mesh_term>
    <mesh_term>Meropenem</mesh_term>
    <mesh_term>Tazobactam</mesh_term>
    <mesh_term>Ceftriaxone</mesh_term>
    <mesh_term>Cycloserine</mesh_term>
    <mesh_term>Linezolid</mesh_term>
    <mesh_term>Piperacillin</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Imipenem</mesh_term>
    <mesh_term>Erythromycin</mesh_term>
    <mesh_term>Erythromycin Estolate</mesh_term>
    <mesh_term>Erythromycin Ethylsuccinate</mesh_term>
    <mesh_term>Erythromycin stearate</mesh_term>
    <mesh_term>Penicillins</mesh_term>
    <mesh_term>Amikacin</mesh_term>
    <mesh_term>Pyrazinamide</mesh_term>
    <mesh_term>Ceftazidime</mesh_term>
    <mesh_term>Colistin</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>Rifabutin</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Rifapentine</mesh_term>
    <mesh_term>Mupirocin</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Cefepime</mesh_term>
    <mesh_term>Cefuroxime</mesh_term>
    <mesh_term>Cefuroxime axetil</mesh_term>
    <mesh_term>Fosfomycin</mesh_term>
    <mesh_term>Trimethoprim, Sulfamethoxazole Drug Combination</mesh_term>
    <mesh_term>Paromomycin</mesh_term>
    <mesh_term>Polymyxins</mesh_term>
    <mesh_term>Aztreonam</mesh_term>
    <mesh_term>Nitrofurantoin</mesh_term>
    <mesh_term>Bacitracin</mesh_term>
    <mesh_term>Neomycin</mesh_term>
    <mesh_term>Sulbactam</mesh_term>
    <mesh_term>Gatifloxacin</mesh_term>
    <mesh_term>Cefotaxime</mesh_term>
    <mesh_term>Cefoxitin</mesh_term>
    <mesh_term>Sulfadiazine</mesh_term>
    <mesh_term>Polymyxin B</mesh_term>
    <mesh_term>Cefixime</mesh_term>
    <mesh_term>Cefdinir</mesh_term>
    <mesh_term>Cloxacillin</mesh_term>
    <mesh_term>Norfloxacin</mesh_term>
    <mesh_term>Penicillin G</mesh_term>
    <mesh_term>Penicillin G Benzathine</mesh_term>
    <mesh_term>Penicillin G Procaine</mesh_term>
    <mesh_term>Cefprozil</mesh_term>
    <mesh_term>Cephalosporins</mesh_term>
    <mesh_term>Oxacillin</mesh_term>
    <mesh_term>Streptomycin</mesh_term>
    <mesh_term>Nafcillin</mesh_term>
    <mesh_term>Ticarcillin</mesh_term>
    <mesh_term>Kanamycin</mesh_term>
    <mesh_term>Cefpodoxime</mesh_term>
    <mesh_term>Cefpodoxime proxetil</mesh_term>
    <mesh_term>Ceftizoxime</mesh_term>
    <mesh_term>Penicillin V</mesh_term>
    <mesh_term>Sultamicillin</mesh_term>
    <mesh_term>Methenamine hippurate</mesh_term>
    <mesh_term>Methenamine mandelate</mesh_term>
    <mesh_term>Cilastatin, Imipenem Drug Combination</mesh_term>
    <mesh_term>Dicloxacillin</mesh_term>
    <mesh_term>Cefoperazone</mesh_term>
    <mesh_term>Dirithromycin</mesh_term>
    <mesh_term>Cefotetan</mesh_term>
    <mesh_term>Lincomycin</mesh_term>
    <mesh_term>Demeclocycline</mesh_term>
    <mesh_term>Ethionamide</mesh_term>
    <mesh_term>Mafenide</mesh_term>
    <mesh_term>Capreomycin</mesh_term>
    <mesh_term>Ceftibuten</mesh_term>
    <mesh_term>Cefaclor</mesh_term>
    <mesh_term>Chloramphenicol</mesh_term>
    <mesh_term>Chloramphenicol succinate</mesh_term>
    <mesh_term>Ticarcillin-clavulanic acid</mesh_term>
    <mesh_term>Tobramycin</mesh_term>
    <mesh_term>Netilmicin</mesh_term>
    <mesh_term>Oxytetracycline</mesh_term>
    <mesh_term>Sulfacetamide</mesh_term>
    <mesh_term>Quinupristin-dalfopristin</mesh_term>
    <mesh_term>Virginiamycin</mesh_term>
    <mesh_term>Enoxacin</mesh_term>
    <mesh_term>Piperacillin, Tazobactam Drug Combination</mesh_term>
    <mesh_term>Methicillin</mesh_term>
    <mesh_term>Bacampicillin</mesh_term>
    <mesh_term>Carbenicillin</mesh_term>
    <mesh_term>Carbenicillin indanyl</mesh_term>
    <mesh_term>Mezlocillin</mesh_term>
    <mesh_term>Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination</mesh_term>
    <mesh_term>Cefamandole</mesh_term>
    <mesh_term>Cefamandole nafate</mesh_term>
    <mesh_term>Cefonicid</mesh_term>
    <mesh_term>Cefmetazole</mesh_term>
    <mesh_term>Loracarbef</mesh_term>
    <mesh_term>Grepafloxacin</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
    <mesh_term>Lomefloxacin</mesh_term>
    <mesh_term>Nalidixic Acid</mesh_term>
    <mesh_term>Sparfloxacin</mesh_term>
    <mesh_term>Methacycline</mesh_term>
    <mesh_term>Tetracycline</mesh_term>
    <mesh_term>Chlortetracycline</mesh_term>
    <mesh_term>Dalfopristin</mesh_term>
    <mesh_term>Novobiocin</mesh_term>
    <mesh_term>Spectinomycin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Sulfamethoxazole</mesh_term>
    <mesh_term>Sulfasalazine</mesh_term>
    <mesh_term>Silver Sulfadiazine</mesh_term>
    <mesh_term>Methenamine</mesh_term>
    <mesh_term>Sulperazone</mesh_term>
    <mesh_term>Sulfisoxazole</mesh_term>
    <mesh_term>Cinoxacin</mesh_term>
    <mesh_term>Trimethoprim</mesh_term>
    <mesh_term>Nitrofurazone</mesh_term>
    <mesh_term>Sulfamethizole</mesh_term>
    <mesh_term>Procaine</mesh_term>
    <mesh_term>Benzoyl Peroxide</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
    <mesh_term>Cilastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

